136 related articles for article (PubMed ID: 3130726)
1. Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
Gillon J; Hussey AJ; Howe SP; Beckett GJ; Prescott RJ
Vox Sang; 1988; 54(3):148-53. PubMed ID: 3130726
[TBL] [Abstract][Full Text] [Related]
2. Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
Biswas R
Vox Sang; 1989; 56(1):63. PubMed ID: 2492703
[No Abstract] [Full Text] [Related]
3. Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients.
Sugg U; Schenzle D; Hess G
Transfusion; 1988; 28(4):386-8. PubMed ID: 3133848
[TBL] [Abstract][Full Text] [Related]
4. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Kusendová K; Gavorník P; Sabaka P; Sviteková K
Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
[TBL] [Abstract][Full Text] [Related]
5. Serum alanine aminotransferase levels among volunteer blood donors: effect of sex, alcohol intake and obesity.
Bizzaro N; Tremolada F; Casarin C; Bonetti P; Noventa F; Diodati G; Drago C; Realdi G
Ital J Gastroenterol; 1992 Jun; 24(5):237-41. PubMed ID: 1623221
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels.
Hetland G; Skaug K; Larsen J; Maland A; Strømme JH; Størvold G
Transfusion; 1990; 30(9):776-9. PubMed ID: 2173175
[TBL] [Abstract][Full Text] [Related]
7. U.K. multicentre study on blood donors for surrogate markers of non-A non-B hepatitis. Part I: Alanine transferase and anti-HBc testing.
Anderson NA; Raafat A; Shwe KH; Barbara J; Contreras M; Fraser ID; Gunson HH; Martlew V; Mijovic V; Goldíe DJ
Transfus Med; 1992 Dec; 2(4):301-10. PubMed ID: 1285043
[TBL] [Abstract][Full Text] [Related]
8. [Occurrence of non-A, non-B post-transfusion hepatitis in heart surgery. Prospective study on the value of the determination of serum alanine aminotransferase and detection of anti-HBc antibodies in blood donors].
Gayet S; Aymard JP; Janot C; Guillemin C; Briquel ME; Gaucher P; Streiff F
Rev Fr Transfus Immunohematol; 1986 Dec; 29(6):485-94. PubMed ID: 3108992
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study.
Stevens CE; Aach RD; Hollinger FB; Mosley JW; Szmuness W; Kahn R; Werch J; Edwards V
Ann Intern Med; 1984 Dec; 101(6):733-8. PubMed ID: 6437308
[TBL] [Abstract][Full Text] [Related]
10. Missed opportunities: ALT and anti-HBc as surrogate tests for hepatitis.
Bettigole R; Shastri KA
J Med; 1997; 28(5-6):363-9. PubMed ID: 9604794
[TBL] [Abstract][Full Text] [Related]
11. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
[TBL] [Abstract][Full Text] [Related]
12. Post-transfusion hepatitis revisited.
Ismay SL; Thomas S; Fellows A; Keller A; Kenrick KG; Archer GT; Wylie BR; Cossart YE
Med J Aust; 1995 Jul; 163(2):74-7. PubMed ID: 7542359
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibody to hepatitis C virus in a blood donor population.
Richards C; Holland P; Kuramoto K; Douville C; Randell R
Transfusion; 1991 Feb; 31(2):109-13. PubMed ID: 1847559
[TBL] [Abstract][Full Text] [Related]
14. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of antibodies to hepatitis C (anti HCV) in blood donors in Rio de Janeiro, Brazil. Its relation to ALT and anti HBC].
Leite NC; Nogueira CM; Coelho HS; Perez R; Martins SJ; Soares JA; Junqueira PC
Arq Gastroenterol; 1992; 29(1):5-11. PubMed ID: 1307202
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of blood donors with elevated serum alanine aminotransferase levels.
Friedman LS; Dienstag JL; Watkins E; Hinkle CA; Spiers JA; Rieder SV; Huggins CE
Ann Intern Med; 1987 Aug; 107(2):137-44. PubMed ID: 3111321
[TBL] [Abstract][Full Text] [Related]
18. The distribution of serum alanine aminotransferase levels in a blood donor population.
Kahn RA; Johnson G; Aach RD; Hines A; Ellis FR; Miller WV
Am J Epidemiol; 1982 Jun; 115(6):929-40. PubMed ID: 6807084
[TBL] [Abstract][Full Text] [Related]
19. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.
Koziol DE; Holland PV; Alling DW; Melpolder JC; Solomon RE; Purcell RH; Hudson LM; Shoup FJ; Krakauer H; Alter HJ
Ann Intern Med; 1986 Apr; 104(4):488-95. PubMed ID: 3006567
[TBL] [Abstract][Full Text] [Related]
20. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.
Allain JP; Hewitt PE; Tedder RS; Williamson LM
Br J Haematol; 1999 Oct; 107(1):186-95. PubMed ID: 10520040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
